Engineering Technologies and Clinical Translation
Volume 3 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy
- Publisher's listprice EUR 175.00
-
72 581 Ft (69 125 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 14 516 Ft off)
- Discounted price 58 065 Ft (55 300 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
72 581 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 27 August 2021
- ISBN 9780323909495
- Binding Paperback
- No. of pages524 pages
- Size 234x190 mm
- Weight 450 g
- Language English
- Illustrations 170 illustrations (70 in full color) 190
Categories
Long description:
Engineering Technologies and Clinical Translation: Volume 3: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy examines the challenges of delivering immuno-oncology therapies, focusing specifically on the development of solutions for drug delivery and its clinical outcomes. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for diseases such as pancreatic cancer, brain tumors where the success of IO so far has been limited. This volume of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy?discusses biomaterial, microfluidic, and biodegradable devices, engineered microbes, personalized medicine, clinical approval process, and many other IO technologies.
Engineering Technologies and Clinical Translation: Volume 3: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy creates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side.
MoreTable of Contents:
1. Engineering solutions for generating CAR-T cells
2. Engineered microbes for cancer immunotherapy
3. Biodegradable scaffolds for priming the immune cells
4. Biomaterials and devices for immunotherapy
5. Engineered devices for tumor immune modulation
6. Microfluidic devices for cancer immunotherapy and vaccination
7. Tumor-on-a-chip devices for immunotherapy
8. Engineered 3D models for cancer immunotherapy
9. Opportunities and challenges of using nanotechnology for cancer immunotherapy
10. Stromal modulation to improve immunotherapy response in cancer
11. Mapping the tumor immune microenvironment
12. Personalized cancer immunotherapy
13. Image-guided cancer immunotherapy
14. Clinical approval process and challenges for cancer immunotherapies
Sozial ist, was Arbeit schafft?: Beschäftigungsfördernde Maßnahmen aus der Sicht von Gerechtigkeits- und Sozialstaatskonzeptionen
19 887 HUF
18 893 HUF
